Lucene search

K
nvd[email protected]NVD:CVE-2022-45611
HistoryAug 22, 2023 - 7:16 p.m.

CVE-2022-45611

2023-08-2219:16:30
CWE-522
web.nvd.nist.gov
1
fresenius kabi pharmahelp
privilege escalation
user login information

CVSS3

9.8

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

NONE

Scope

UNCHANGED

Confidentiality Impact

HIGH

Integrity Impact

HIGH

Availability Impact

HIGH

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

AI Score

9.6

Confidence

High

EPSS

0.002

Percentile

52.1%

An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.

Affected configurations

Nvd
Node
fresenius-kabipharmahelpMatch-
AND
fresenius-kabipharmahelp_firmwareMatch5.1.759.0
VendorProductVersionCPE
fresenius-kabipharmahelp-cpe:2.3:h:fresenius-kabi:pharmahelp:-:*:*:*:*:*:*:*
fresenius-kabipharmahelp_firmware5.1.759.0cpe:2.3:o:fresenius-kabi:pharmahelp_firmware:5.1.759.0:*:*:*:*:*:*:*

CVSS3

9.8

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

NONE

Scope

UNCHANGED

Confidentiality Impact

HIGH

Integrity Impact

HIGH

Availability Impact

HIGH

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

AI Score

9.6

Confidence

High

EPSS

0.002

Percentile

52.1%

Related for NVD:CVE-2022-45611